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http://www.biomedcentral.com/1471-2180/14/303RESEARCH ARTICLE Open AccessExtracellular DNA release confers heterogeneity in
Candida albicans biofilm formation
Ranjith Rajendran1, Leighann Sherry1, David F Lappin1, Chris J Nile1, Karen Smith2, Craig Williams2,
Carol A Munro3 and Gordon Ramage1*Abstract
Background: Biofilm formation by Candida albicans has shown to be highly variable and is directly associated with
pathogenicity and poor clinical outcomes in patients at risk. The aim of this study was to test the hypotheses that
the extracellular DNA release by C. albicans is strain dependent and is associated with biofilm heterogeneity.
Results: Initially, biofilm formed by C. albicans high biofilm formers (HBF) or low biofilm formers (LBF) were treated
with DNase to find whether eDNA play a role in their biofilm formation. Digestion of biofilm eDNA significantly
reduced the HBF biofilm biomass by five fold compared to untreated controls. In addition, quantification of eDNA
over the period of biofilm formation by SYBR green assay demonstrate a significantly higher level of 2 to 6 fold in
HBF compared to LBF. Biochemical and transcriptional analyses showed that chitinase activity and mRNA levels of
chitinase genes, a marker of autolysis, were upregulated in 24 h biofilm formation by HBF compared to LBF,
indicating autolysis pathway possibly involved in causing variation. The biofilm biomass and eDNA release by single
(Δcht2, Δcht3) and double knockout (Δcht2/Δcht3) chitinase mutants were significantly less compared to their
parental strain CA14, confirming the role of chitinases in eDNA release and biofilm formation. Correlation analysis
found a positive correlation between chitinases and HWP1, suggesting eDNA may release during the hyphal
growth. Finally, we showed a combinational treatment of biofilms with DNase or chitinase inhibitor (acetazolamide)
plus amphotericin B significantly improved antifungal susceptibility by 2 to 8 fold.
Conclusions: Collectively, these data show that eDNA release by C. albicans clinical isolates is variable and is
associated with differential biofilm formation. Digestion of biofilm eDNA by DNase may provide a novel therapeutic
strategies to destabilise biofilm growth and improves antifungal sensitivity.
Keywords: Candida albicans, Biofilm, eDNA, ChitinasesBackground
Candida albicans is a dimorphic fungal pathogen that
causes both superficial and systemic candidiasis [1]. In-
vasive systemic forms of the disease affect at-risk pa-
tients and can lead to mortality rates as high as 63% in
some instances [2]. The disease is multifactorial [3], yet
the capacity of C. albicans to form biofilms has been
identified as a pivotal factor to patient outcomes [4,5].
These structures are found frequently associated with in-
dwelling medical devices, as well as biological surfaces
such as the mucosa [6], and are clinically important due* Correspondence: gordon.ramage@glasgow.ac.uk
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unless otherwise stated.to their high recalcitrance to antifungal treatment [7].
However, there is increasing evidence in the literature
that C. albicans biofilm formation is heterogeneous,
which has a direct impact upon treatment and patho-
genicity [4,8-10]. Studies have indicated that depending
on the ability to form a biofilm, or not, has a bearing on
patient outcomes, though the conclusions from some of
these studies are diametrically opposed [4,9]. Therefore,
rather than defining biofilm formation as an absolute
parameter we have recently described a series of clinical
isolates with a differential ability to form biofilms, in
which high biofilm forming (HBF) isolates displayed a
greater pathogenic capacity and lower antifungal sensitiv-
ity when compared to low biofilm forming (LBF) isolates
[10]. However, the mechanisms underlying the difference
in biofilm formation are not yet fully understood.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing characteristic of biofilms, providing a structural scaf-
fold whilst coincidentally facilitating protection from
external factors, including antifungal agents [7,11]. Typ-
ical fungal biofilm ECM is a heterogeneous substance
consisting of exopolysaccharides, proteins, surfactants,
lipids and water [12,13], though recent studies have
shown the presence of another important component
extracellular DNA in fungal biofilm matrix [13,14].
These studies demonstrated that eDNA plays a signifi-
cant role with respect to structural stability and as a
consequence antifungal sensitivity. In both C. albicans
and A. fumigatus it was shown that addition of exogen-
ous DNA significantly improved biofilm formation, and
that depletion of biofilm eDNA through the addition of
DNase adversely affects the biomass [13,14]. It can be
inferred from bacterial biofilm studies that eDNA has a
multifactorial purpose, namely as a nutrient source [15],
facilitator of genetic information exchange [16], con-
tributor to biofilm stability and dispersal [17-20], and as
an antimicrobial resistance factor [21,22]. The mechan-
ism of eDNA release in biofilm environment is not yet
fully understood, though studies in bacterial species sug-
gests various mechanisms that are potentially respon-
sible for this process, including cell lysis [23,24]. We
recently demonstrated the association of the chitinase
regulated autolytic pathway with eDNA release in A.
fumigatus [14], however, chitinase activity in C. albicans
biofilms with respect to eDNA has yet to be studied.
Given that eDNA contributes to ECM integrity, and
ECM is a key factor in promoting biofilm formation, we
hypothesised that the capacity to release eDNA through
differential chitinase activity may be an underlying
mechanism supporting biofilm heterogeneity.Methods
Isolates and maintenance
C. albicans SC5314 and a series of routine patient anon-
ymised clinical bloodstream isolates (n = 6) were col-
lected under the approval of the NHS Scotland Caldicott
Gaurdians from the Royal Hospital for Sick Children
(Yorkhill Division), Glasgow, UK, as part of candidae-
mia epidemiology surveillance study were used
throughout this study. Furthermore, chitinase mutants
Δcht2, Δcht3, Δcht2/Δcht3, including the parental
strain CA14 were also used. Isolates were stored on
Sabouraud dextrose agar (Oxoid, Basingstoke, UK) at
4°C. All C. albicans strains were grown on YPD at 37°C
overnight. Cells were then washed and resuspended in
appropriate media to the desired concentration, as de-
scribed previously [25]. All procedures were carried
out in a laminar flow cabinet (Hera Safe laminate flow
cabinet, Kendro, model K515).Assessment of biofilm formation
The growth rate of the clinical isolates was first assessed.
Each isolate was standardised to 1 × 104 cells/mL in YPD
dispensed into each well of a 96 well round-bottom plate
and incubated at 37°C for 24 h. The absorbance was mea-
sured at 530 nm every 1 h in a microtitre plate reader
(FluoStar Omega, BMG Labtech). Each isolate was tested
in duplicate and repeated on three independent occasions.
Negative controls containing no C. albicans were included
for background correction. For biofilm screening isolates
were processed as described previously [10]. Biofilms were
then grown in a 96 well flat-bottomed polystyrene plate
(Corning Incorporated, NY, USA) at 37°C for 24 h as de-
scribed previously [25]. Following incubation, biofilms
were carefully washed twice with PBS to remove any non-
adherent cells and biomass of each isolate assessed using a
crystal violet assay (CV) [26]. Air dried biofilms were
stained with 0.05% w/v CV for 20 min, washed to remove
excess stain, then destained with 100% ethanol. This was
transferred to a new 96 well plate and absorbance was read
at 570 nm. Isolates with CV absorbance of ≥1.5 were classi-
fied as high biofilm former (HBF) and ≤0.5 were classified
as low biofilm former (LBF), as previously described [10].
Effect of DNase treatment on preformed biofilms
The role of eDNA in C. albicans biofilm formation was
first investigated by depletion of eDNA within the bio-
film using a hydrolytic enzyme DNase I. DNase I from
bovine pancreas (Sigma-Aldrich) was prepared in
0.15 M NaCl supplemented with 5 mM of MgCl2. Bio-
films of HBF (n = 3) and LBF (n = 3) isolates were grown
in RPMI-1640 as described above. Following incubation,
biofilms were washed with PBS and treated with
256 μg/mL of DNase (Sigma-Aldrich) for 24 h at 37°C, a
concentration previously shown to decrease fungal bio-
film biomass [14,27]. Untreated controls were also in-
cluded for direct comparison. Biofilms were then
washed twice with PBS and the biomass was scraped
from the surface and passed through 0.22 μM mem-
brane filters. Biofilms retained on the filters were dried
overnight at 60°C and then dry weight measurements
were taken for each isolate, as described previously [28].
Measurement of each isolate was carried out in dupli-
cate, on three independent occasions.
Assessment of extracellular DNA release
C. albicans isolates with LBF (n = 3), HBF (n = 3), CA14,
and chitinase mutants Δcht2, Δcht3 and Δcht2/Δcht3 bio-
films were grown in RPMI-1640 for 4 and 24 h at 37°C.
The quantity of eDNA release was measured using a mi-
croplate fluorescence assay (MFA) using a DNA binding
dye (SYBR® Green I), as previously described [14]. Briefly,
SYBR® Green I (Invitrogen) was added to biofilm superna-
tants in a black well microtitre plate (Costar3603;
Table 1 C. albicans primers used for qPCR
Gene Sequence (5′ - 3′) Function
ALS3 F - CAACTTGGGTTATTGAAACAAAAACA Adhesin
R - AGAAACAGAAACCCAAGAACAACCT
HWP1 F - GCTCAACTTATTGCTATCGCTTATTACA Hyphal wall protein
R - GACCGTCTACCTGTGGGACAGT
CHT2 F – TGATTTATTATCCAAAGTCCCACTTG Chitinase
R – TTGAATTGGCCATTGATTGAA
CHT3 F - TGCTACTATTCCAGATGACAAAGAAATT Chitinase
R - TTCAGTGATGATAGCAGGTGGTTT
ACT1 F - AAGAATTGATTTGGCTGGTAGAGA Actin - housekeeping
R - TGGCAGAAGATTGAGAAGAAGTTT
Rajendran et al. BMC Microbiology 2014, 14:303 Page 3 of 9
http://www.biomedcentral.com/1471-2180/14/303Corning) at a ratio of 1:4. Binding of this dye produces
fluorescence directly proportional to DNA concentration.
The levels of eDNA were quantified using a fluorescence
plate reader (Fluostar Optima; BMG Labtech) at 485 and
518 nm, respectively. The concentration of eDNA in the
sample was quantified using the DNA standard curve as
previously described [29]. In addition, optical density of the
culture was measured at 530 nm simultaneously for nor-
malising the relative fluorescence units (RFU) data. Each
isolate was tested in duplicate, on three separate occasions.
Fluorescence microscopy
Standardised C. albicans (1 × 106 cells/ml) were inocu-
lated in RPMI medium onto Thermanox™ coverslips
(13 mm) within a 24-well tissue culture plate, then incu-
bated for 24 h at 37°C. These were gently rinsed with
PBS and stained according to the manufacturers’ in-
structions with 5 μM calcofluor white (Invitrogen),
which binds chitin and beta-glucans of fungal cell walls,
and with 20 μM propidium iodide (PI) (Sigma), which
stains the DNA present within a biofilm. Biofilm growth
and accumulation of eDNA were visualized under a fluor-
escence microscope (Motic BA400 Colorview system) at
Ex350/Em400 for calcofluor white, and Ex540/Em525 for pro-
pidium iodide. Representative images from 10 fields were
taken and one from each group was digitally photographed.
Quantifying chitinase activity
C. albicans chitinase activity was quantified from isolates
with LBF (n = 3) and HBF (n = 3) after 4 and 24 h of bio-
film formation using a fluorometric chitinase assay kit
(Sigma, United Kingdom), as per the manufacturer’s in-
structions. Following biofilm development, supernatants
were collected at 4 and 24 h, and an appropriate volume
of each sample was incubated with a substrate working
solution (4-methylumbelliferyl N-acetyl-β-d-glucosami-
nide) at 37°C for 30 min. Fluorescence was then quanti-
fied at Ex360/Em450. Appropriate positive and negative
controls included in the kit were added to each plate.
Chitinase activity was calculated and expressed as a ratio
between chitinase units and optical density of culture
(U/OD). Each isolate was measured in duplicate, on
three separate occasions.
Quantitative gene expression
C. albicans HBF (n = 3) and LBF (n = 3) biofilms were
prepared in 24 well polystyrene plates as described above
for 4 and 24 h at 37°C. Quantitative analysis of tran-
scriptional changes within these biofilms was performed
as previously described [30]. Briefly, RNA was extracted
by mechanical disruption in TRIzol (Invitrogen) and
purified using an RNeasy MinElute cleanup kit (Qiagen,
Crawley, United Kingdom) as per the manufacturer’s in-
structions. RNA was quantified and its quality determinedusing a NanoDrop spectrophotometer (ND-1000; Thermo
Scientific, Loughborough, United Kingdom). Then, cDNA
was synthesised with a high-capacity RNA-to-cDNA mas-
ter mix (Applied Biosystems), using a MyCycler PCR ma-
chine (Bio-Rad, Hertfordshire, United Kingdom), and was
stored at −20°C for expression analysis. The expression of
the chitinase genes CHT2 and CHT3 and markers of hy-
phal cell growth and adhesion (HWP1 and ALS3) were
then assessed using quantitative reverse transcription-PCR
(RT-PCR) with SYBR® GreenER™ (Invitrogen), according to
the manufacturer’s instructions. Primer sequences for these
genes are shown in Table 1. The individual gene expression
levels were then calculated using the 2−ΔCT method for dif-
ferent phases and normalized to the ACT1 housekeeping
gene. All isolates were tested in duplicate for this
experiment.
Scanning electron microscopy
C. albicans single (Δcht2, Δcht3), double knockout
(Δcht2/Δcht3) chitinase mutants and their parental
strain CA14 were standardised and grown as biofilm in
RPMI-1640 directly onto Thermanox™ coverslips (Nunc,
Roskilde, Denmark) for 24 h. Following biofilm develop-
ment, biofilms were carefully washed with PBS before
fixation in 2% para-formaldehyde, 2% gluteraldehyde
and 0.15 M sodium cacodylate, and 0.15% w/v Alcian
Blue, pH 7.4, and prepared for scanning electron micros-
copy (SEM), as previously described [31]. The samples were
sputter-coated with gold and viewed under a JEOL JSM-
6400 SEM. Images were assembled using Photoshop soft-
ware (Adobe, San Jose, CA, USA) at magnification × 1000.
Biofilm susceptibility testing in the presence of DNase
and azetazolamide
The impact of eDNA and chitinases on amphotericin B
sensitivity was assessed using a hydrolytic enzyme
DNase I and a chitinase inhibitor acetazolamide ([AZE]
Sigma-Aldrich). C. albicans LBF (n = 3), HBF (n = 3) and
SC5314 were standardized to 1 × 106 cells/ml in RPMI-
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for 4 and 24 h. Preformed biofilms were washed twice
with PBS and treated with serially diluted AMB ±DNase
(256 μg/ml) or ± AZE (256 μg/ml). The concentrations
of DNase and AZE were previously shown to be effect-
ively disrupting the biomass and improve antifungal sen-
sitivity [14,27]. Biofilms were incubated for a further
24 h at 37°C before metabolic activity assessed using the
XTT assay, as described previously [32].
Statistics
Analysis of variance (ANOVA) and t-tests were used to in-
vestigate independent sample data. A Bonferroni correction
for multiple comparisons was applied to the data where ap-
propriate. SPSS (Version 11, Chicago, USA) was used for
these analysis and GraphPad Prism (Version 4, La Jolla,
USA) for the production of the figures. The Spearman’s rho
correlation coefficient was determined to investigate the re-
lationship between the parameters measured. A p value of
less than 0.05 was considered significant.
Results
Candida albicans eDNA release is correlated with biofilm
formation and promotes antifungal resistance
Initially, we assessed C. albicans biofilm formation by
six bloodstream isolates defined as either low biofilmFigure 1 Variation in C. albicans biofilm formation and eDNA release.
biofilms in 96 well flat-bottom microtitre plates at 37°C for 24 h. (A) Biofilm bi
data represents mean ± SD. (B) Biofilms were treated ± 256 μg/ml DNase for a
Biomass retained on the filters was dried overnight at 60°C and dry weight mea
show the disruptive effect of DNase on the biofilms, data represents mean ± SE
DNA binding dye SYBR® Green I. Fluorescence was measured after 4 and 24 h a
the fluorescence data, data represents mean ± SD. Each isolate was tested in duformer (LBF, n = 3) or high biofilm former (HBF, n = 3)
based on biomass quantification. A significant difference
in biofilm formation was observed between isolates with
LBF and HBF, where 11.6× more (p = 0.0035) biomass
was observed in the latter group (Figure 1A). We then
evaluated whether the presence of eDNA contributed to
C. albicans biofilms formation. To do so we investigated
how each LBF and HBF isolate responded to DNase treat-
ment. A significant biomass (dry weight) reduction was
observed for the HBF (p < 0.01), with a 5-fold decrease in
biomass compared to untreated controls (Figure 1B). In
comparison, isolates with the LBF phenotype did not show
any significant biomass reduction. To further investigate
the hypothesis that eDNA preferentially supported biofilm
growth, we evaluated its release from both HBF and
LBF at 4 and 24 h using SYBR green I assay. eDNA re-
lease was significantly greater in isolates with HBF com-
pared to LBF at both 4 h and (2.78 fold, p < 0.05) and
24 h (5.89 fold, p < 0.01) (Figure 1C). Moreover, eDNA re-
lease increased significantly by a further 2.79 fold (p =
0.0221) in HBF isolates between 4 and 24 h. No differ-
ences in growth rates were observed between the 6 test
isolates (Additional file 1: Figure S1).
Next, the impact of eDNA on AMB sensitivity was
then tested to determine its role in antifungal resistance.
It was shown that isolates with LBF were up to 8-foldC. albicans isolates with LBF (n = 3) and HBF (n = 3) were grown as
omass was assessed spectrophotometrically by reading CV absorbance,
further 24 h before being passed through 0.22 μM membrane filter.
surements taken. In addition, biofilms were stained with CV and imaged to
. (C) Isolates were grown as biofilms for 4 and 24 h in the presence of the
t Ex485/Em518. Absorbance was measured simultaneously for normalising
plicate, on three independent occasions. *#p < 0.05, **p < 0.01.
Table 2 MIC of amphotericin B against C. albicans
SC5314, LBF and HBF
Minimum inhibitory concentrations (MICs)
Strain 4 h biofilm 24 h biofilm
AMB MIC50
*
(mg/L)
FC** +
DNase
FC +
AZE
AMB MIC50
(mg/L)
FC +
DNase
FC +
AZE
SC5314 <0.0313 1 1 0.5 4 2
LBF 0.0313 1 1 0.25 – 0.5 1 - 2 1
HBF 0.125 – 0.25 1 - 2 1 0.25 - 1 4 - 8 2
*MIC50 – Minimum concentration of AMB at which 50% reduction in viability
assessed by XTT assay.
**FC – Fold change in MIC of AMB in the presence and absence of DNase or
acetazolamide (AZE).
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However, when comparing these biofilm subsets at 24 h
there was only a 2-fold difference in MIC (Table 2). The
addition of DNase during AMB treatment did not have
an impact on isolates with LBF at 4 h, with only a 2-fold
difference observed at 24 h with DNase treatment. In
contrast, isolates with HBF were most susceptible to
AMB +DNase therapy at both time points, particularly
24 h where up to 8-fold decrease in MIC were observed
in the presence of DNase. The addition of DNase with
AMB increased AMB sensitivity by up to 2 and 8-fold in
HBF isolates from 4 and 24 h biofilms, respectively,Figure 2 Chitinases play a role in C. albicans biofilm formation. Three
cells/ml in RPMI-1640 and grown in 24 well microtitre plates at 37°C for 4 a
substrate working solution for 30 min at 37°C. Fluorescence was measured at
to isolate biomass. Each isolate was measured in duplicate, on three separate
with PBS and RNA extracted using the TRIzol method, cDNA synthesised and
(C). Percentage of gene expression is shown as log10 mean ± SD relative to howhereas, those LBF isolates showed no change at 4 h, and
only a 2 fold change at 24 h (Table 2).
Differential expression of Candida albicans chitinase activity
is correlated with eDNA release and biofilm formation
Based on previous work from our group, which showed a
positive correlation between chitinase activity in Aspergil-
lus fumigatus biofilms and eDNA release [14], we decided
to evaluate whether this property was also observed in C.
albicans biofilms. Although no differences in chitinase ac-
tivity were identified with biochemical assay between LBF
and HBF isolates at 4 h, a significant change of ~3-fold
greater activity detected at 24 h (p < 0.05) with HBF com-
pared to LBF (Figure 2A). Furthermore, transcriptional
analysis found no difference in CHT2 expression at 4 h be-
tween the two biofilm subsets, a significant up-regulation
by 23% (p < 0.05) was observed at 24 h in those with HBF
compared to those with LBF (Figure 2B). In addition, des-
pite CHT3 expression being increased by 4-fold and 3-fold
in isolates with HBF than LBF at 4 and 24 h, respectively,
no significant difference between the groups was observed
(Figure 2C). In addition, the expression of biofilm-related
genes HWP1 and ALS3 in C. albicans biofilms was evalu-
ated and it was found that these were up-regulated in iso-
lates with HBF. Despite ALS3 and HWP1 expression being
increased in HBF by 11× (p = 0.1143) and 18× (p = 0.1447)C. albicans isolates with LBF and HBF were standardised to 1 × 106
nd 24 h. (A) Supernatants were retained and mixed with a chitinase
360 and 450 nm and chitinase activity represented at U/OD, normalised
occasions. (B-C) Biofilms with LBF (n = 3) and HBF (n = 3) were washed
real-time PCR used to measure the expression of CHT2 (B) and CHT3
usekeeping gene ACT1. *p < 0.05.
Table 3 Spearman’s rho correlation analysis
Spearman’s rho Biomass Chitinase HWP1 ALS3
eDNA Correlation Coefficient .829* .771* .886** .829*
Sig. .021 .036 .009 .021
Chitinase Correlation Coefficient .771* .771* .600
Sig. .036 .036 .104
*Correlation is significant at the 0.05 level.
**Correlation is significant at the 0.01 level.
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only significant difference in the transcriptional analysis
was observed at 24 h where LBF had 18× less expression
of ALS3 (p = 0.0102) than HBF (Figure 3B).
To investigate the relationship between eDNA release,
chitinase activity, biofilm biomass and genes related to
biofilm formation (HWP1 and ALS3), a Spearman’s rho
correlation analysis was performed (Table 3). A signifi-
cant correlation was observed between eDNA release and
biomass (p < 0.01), chitinase activity (p < 0.01), and expres-
sion of HWP1 (p < 0.05) and ALS3 (p < 0.05) at 24 h. A
significant positive correlation was also found between
chitinase activity and expression of HWP1 (p < 0.05) in
24 h biofilms (Table 3).
Compromising Candida albicans chitinase activity affects
isolates biofilm formation and antifungal sensitivity
C. albicans single and double knockout mutants Δcht2,
Δcht3 and Δcht2/Δcht3 were assessed to confirm
whether these chitinases played a role in eDNA release
and biofilm formation. These all showed a reduction inFigure 3 Expression of biofilm related genes is up-regulated in
C. albicans isolates with HBF. Biofilms with LBF (n = 3) and HBF
(n = 3) were grown for 4 (A) and 24 h (B) before RNA extracted,
cDNA synthesised and qPCR used to measure the expression of
ALS3 and HWP1. Each individual isolate was measured in duplicate.
Percentage of gene expression is represented by mean ± SD relative
to housekeeping gene ACT1. *p < 0.05.biofilm biomass when compared to their parental
strain CA14. However, a significant reduction was
found only with Δcht3 (p < 0.05) and Δcht2/Δcht3 (p <
0.005) (Figure 4A). To investigate whether this reduc-
tion in biomass is caused by presence of eDNA, the
biofilms were treated with DNase. Here a significant
reduction in biofilm biomass by 2-fold was observed
with DNase treatment in CA14 compared to untreated
controls (p < 0.01). Conversely, no significant reduc-
tion was observed with either single or double knock-
out mutants (Figure 4A). The reduction in biofilm
formation by all the knockout mutants was confirmed
by microscopy (Figure 4B). SEM imaging showed re-
duced biomass in these isolates compared to CA14,
with Δcht3 showing the clearest visual difference, provid-
ing evidence that chitinases plays a role in C. albicans bio-
film formation. eDNA release was also quantified in these
mutants. All knockout strains had significantly reduced
eDNA release after 24 h. The greatest reduction was in
Δcht2, where a significant eDNA reduction of 53% (p <
0.05) was measured compared to the wild-type, followed
by Δcht2/Δcht3 with reduction of 50% (p = 0.0061), and
Δcht3 where eDNA release was reduced by 26% (p =
0.0161) (Figure 4C). The level of eDNA present in these
knockout mutants was confirmed visually using fluores-
cence imaging. The presence of eDNA in the parental
strain CA14 is shown by the abundance of red/pink fluor-
escence, which was notably reduced in the single knock-
outs Δcht2 and Δcht3, and completely absent from the
double knockout Δcht2/Δcht3 (Figure 4D).
Finally, to test whether pharmacological inhibition of
chitinases impacted antifungal sensitivity, AZE was used in
combination with AMB. It was shown that the addition of
AZE did not alter AMB sensitivity in any of the LBF bio-
films at 4 h and 24 h. However, isolates with HBF had up to
a 2 fold decrease in MIC50 at both 4 and 24 h (Table 2).
Discussion
Our group have recently described that biofilms formed
by different clinical isolates of C. albicans are heteroge-
neous. Significant variation in their ability to form and
maintain biofilm structure exists between bloodstream
isolates, which was shown not only to impact biofilm for-
mation, but also pathogenicity and antifungal sensitivity
Figure 4 Compromising chitinase activity decreases eDNA release and biofilm formation in C. albicans. C. albicans Δcht2, Δcht3, Δcht2/
Δcht3 and parental strain CA14 biofilms were grown in 96 well microtitre plates for 24 h at 37°C in RPMI (A) Following biofilm development,
biofilms were carefully washed with PBS and incubated in RPMI for a further 24 h, ± 256 μg/ml DNase. Biomass assessed spectrophotometrically
by measuring CV absorbance at 570 nm. Also CV stained biofilms were digitally imaged to show the difference in biofilm formation and effect of
DNase treatment. §P < 0.05, §§ p < 0.01. (B) C. albicans Δcht2, Δcht3, Δcht2/Δcht3 and wild type CA14 (×1000) were grown on Thermanox™
coverslips for 24 h at 37°C. Biofilms were then processed and viewed on a JEOL JSM-6400 scanning electron microscope and images assembled
using Photoshop software. Note the reduction in biofilm biomass in Δcht3 and Δcht2/Δcht3. (C) eDNA release was measured after 4 and 24 h
using SYBR green I assay, normalised to each isolates biomass. Each isolate was measured in duplicate, on three separate occasions. *p < 0.05,
**p < 0.01. (D) Biofilm growth (hyphal cells indicated by arrow head) and accumulation of eDNA (Indicated by arrow) were visualized under a
fluorescence microscope (Motic BA400 Colorview system) at an Ex/Em wavelengths of 350/400 nm for calcofluor white and 540/525 nm for
propidium iodide. One representative from each group was digitally photographed.
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useful in developing better management strategies, both in
terms of antifungal therapy, but potentially also for devel-
opment of new molecular diagnostics. The data presented
herein describes a novel role for eDNA release in confer-
ring heterogeneity during biofilm formation by C. albi-
cans, which is associated with chitinase regulated autolytic
events, and which contributes to biofilm associated anti-
fungal resistance.
There have been limited studies to date examining the
presence and role of eDNA in C. albicans biofilms
[13,27,33]. These studies demonstrate that the quantity
of eDNA in biofilms varied considerably with the growth
medium used, with RPMI showing a significantly higher
accumulation of eDNA in ECM compared to other
tested media [13]. We reported that RPMI consistently
supports optimal biofilm formation for C. albicans [10].
Given that eDNA was associated with high levels of bio-
film formation it was hypothesised that this may explain
the underlying mechanism for the heterogeneity, i.e.
those isolates with the propensity to form biofilms may
release more eDNA than isolates forming structurallysimple biofilms. This is supported by the data showing
that addition of exogenous DNA has been shown to sig-
nificantly improve biofilm biomass [14,34]. Moreover,
there are studies highlighting the importance of eDNA
within mixed C. albicans and bacterial biofilms [33,35].
To test these hypotheses two groups of contrasting bio-
film forming abilities were investigated. Based on two
biomass quantification assays the isolates were categorised
as LBF and HBF, from which eDNA release was initially
evaluated. Here the levels of eDNA observed were greater
in isolates with HBF, which also increased with biofilm
maturity, which is a similar finding to that reported in
studies of A. fumigatus biofilm development [14].
The release of eDNA in fungal biofilms is hypothesised
to be an end product of autolysis, a process controlled by
various hydrolases, including chitinases [14,36]. C. albicans
have also been shown to possess complex chitinase families
that hydrolyse chitin molecules in fungal cell wall [37].
These enzymes are known to be involved in spore forma-
tion, hyphal growth, hyphal branching and septum forma-
tion. There are four chitinase genes known in C. albicans
(CHT1-4), though their function remains unclear. CHT2
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hyphal morphogenesis and are more active in the hyphal
form [38]. Here it was reported that these enzymes were
transcriptionally expressed and biochemically active during
the release of eDNA, which in turn contributes towards
biofilm formation. Indeed, correlation analysis demon-
strates the functional relationship between eDNA release,
chitinase activity and biofilm formation. Furthermore, a
positive correlation between chitinase activity and a hy-
phal cell marker HWP1 suggest the involvement of chiti-
nases in hyphal growth, which in turn contributes to
eDNA release. This may explain the morphological differ-
ences between the HBF and LBF, of which the former dem-
onstrates more filamentous growth [10]. It was also shown
that compromising chitinase activity through gene deletion
of Δcht2, Δcht3 and Δcht2/Δcht3 significantly affects eDNA
release and biofilm formation, which suggests a role for
chitinases in the maintenance and architecture of C. albi-
cans biofilms.
From a translational perspective, the mechanism of
eDNA release could represent an Achilles heal in the man-
agement of tenacious HBF isolates. eDNA release was
shown to improve AMB resistance, demonstrated through
DNase combinational treatments and also through
pharmacological inhibition of chitinases that may regulate
eDNA release. Collectively, these data demonstrate the pos-
sibility of improving our treatment of these infections
through rationally designed strategies. Mismanagement also
has important repercussions, as it has been shown that
treatment with sub-MIC levels of antifungals causes an in-
crease in chitin content within Candida species, which re-
lates to decreased antifungal sensitivity [39,40]. Moreover, a
recent study has shown the use of sub-lethal concentrations
of antibiotics leads to increased autolysis, eDNA release
and biofilm formation in bacteria [41]. Tumbarello and
colleagues identified inadequate antifungal therapy as a pre-
dictor of patient mortality [42], with other studies highlight-
ing the importance of efficient and appropriate treatment
of candidaemia cases [43,44]. Therefore, careful consider-
ation must be given with regards to antifungal use as inef-
fectual therapy can lead to increased antifungal resistance
and increased hospital lengths of stay.
Conclusions
The data from this study showed a variation in biofilm
formation among C. albicans isolates and how it affects
the antifungal sensitivity. Strain dependent eDNA re-
lease and chitinase activity is associated with biofilm
formation. Finally, pharmacological inhibition of eDNA
by DNase or AZE reduced biofilm resistance to AMB in
C. albicans. Thus, we establish a potential mechanism
regulating biofilm heterogeneity and antifungal resistance,
and that targeting eDNA may provide an effective strategy
for management of biofilm based infections.Additional file
Additional file 1: Figure S1. Variation in Candida albicans biofilm
formation is independent of growth kinetics. The growth kinetics of
C. albicans isolates with LBF (grey circle) and HBF (black square) was
assessed over 24 h, with absorbance read at 530 nm every hour. Isolates
with LBF (n = 3) and HBF (n = 3) were grown in duplicate, on three
separate occasions. Data represents mean value.
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